{
  "ticker": "JNJ",
  "target_date": "2025-11-10",
  "actual_date": "2025-11-10",
  "collected_at": "2025-12-08T12:30:47.312721",
  "price": {
    "open": 184.83,
    "high": 187.23,
    "low": 183.95,
    "close": 187.22129821777344,
    "volume": 5323800,
    "change_1d_pct": 0.99,
    "change_7d_pct": -0.34,
    "change_30d_pct": 3.74
  },
  "technicals": {
    "rsi_14": 39.98,
    "sma_20": 188.38,
    "sma_50": 183.35,
    "macd": 0.363,
    "macd_signal": 1.063,
    "macd_histogram": -0.7,
    "bb_upper": 193.63,
    "bb_lower": 183.14,
    "price_vs_sma20_pct": -0.62,
    "price_vs_sma50_pct": 2.11,
    "volume_ratio": 0.67
  },
  "fundamentals": {
    "market_cap": 488002715648,
    "pe_ratio": 19.551159,
    "forward_pe": 19.10849,
    "price_to_book": 6.147753,
    "price_to_sales": 5.2958007,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.53,
    "pct_from_52w_low": 43.98
  },
  "macro": {
    "spy": {
      "price": 681.44,
      "change_1d_pct": 1.56,
      "change_7d_pct": -0.09
    },
    "vix": {
      "level": 17.6,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.11
    },
    "dollar_index": {
      "level": 99.62
    },
    "gold": {
      "price": 4111.8
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Nasdaq falls as tech shares come under pressure again; S&P 500 is little changed: Live updates",
      "source": "CNBC",
      "datetime": 1762797738,
      "summary": "The S&P 500 fell on Tuesday, pressured by declines in tech, following strong gains in the previous session.",
      "url": "https://finnhub.io/api/news?id=105e1f6f3ae9fc78de90a9d7cbbc44263746600d6bc0b140d183f478831ca146"
    },
    {
      "headline": "Black Hair Accessories Brand Targets $50M Revenue By 2030 With New Products, Market Expansion",
      "source": "Yahoo",
      "datetime": 1762776000,
      "summary": "President and CEO Joni Odum has driven plans to boost revenue at Firstline Brands to $50M within the next five years.",
      "url": "https://finnhub.io/api/news?id=220f61b8cbf438eb80d437839d481b619c85ffd88697941594b5b0dc36823085"
    },
    {
      "headline": "Johnson & Johnson: 2 Recent FDA Wins And Earnings Beat Warrant 'Buy' Rating",
      "source": "SeekingAlpha",
      "datetime": 1762756013,
      "summary": "Johnson & Johnson posts strong Q3 2025 with robust sales, new acquisitions, and FDA approvals expanding oncology and CNS markets. Learn why JNJ stock is a buy.",
      "url": "https://finnhub.io/api/news?id=d615c650873ad1085006d4d02b5a10d9d72714d7cd21b29f37ffb880da4e34b6"
    },
    {
      "headline": "Jim Cramer Says Haleon\u2019s \u201cStock\u2019s Been Struggling\u201d",
      "source": "Yahoo",
      "datetime": 1762689291,
      "summary": "Haleon plc (NYSE:HLN) is one of the stocks Jim Cramer recently discussed. Cramer highlighted the stock\u2019s struggles, as he commented: \u201cWith Kimberly-Clark shelling out nearly $49 billion to buy Kenvue, which was originally J&J\u2019s over-the-counter medicine business, I think it\u2019s time to check in with H",
      "url": "https://finnhub.io/api/news?id=7ef28b8189f80c073dc2d4a4aba6897ba0e59c6e8ec497c1ea3cf59fd2200846"
    },
    {
      "headline": "Jim Cramer Says He \u201cBelieved in\u201d Bristol-Myers\u2019 Cobenfy But \u201cIt\u2019s Not Selling Well at All\u201d",
      "source": "Yahoo",
      "datetime": 1762574807,
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer recently shared thoughts on. Cramer showed his disappointment in the company\u2019s schizophrenia medicine sales, as he commented: \u201cLook, I, my Charitable Trust owns Bristol, looks like a mistake because I, I believed in Cobenfy, whi",
      "url": "https://finnhub.io/api/news?id=1c0e6a96a4f9a2dbd17c572939e5e0e5277b900d87fee2c00774f2b49c5aab14"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-10",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/xslF345X05/ownership.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    },
    {
      "form": "8-K",
      "date": "2025-10-14",
      "description": "jnj-20251014.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}